• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血友病的预防性替代治疗]

[Prophylactic replacement therapy of hemophilia].

作者信息

Nowak K, Zalewska-Szewczyk B, Stolarska M, Bodalski J

机构信息

II Kliniki Chorób Dzieciecych AM w Lodzi.

出版信息

Pol Tyg Lek. 1994;49(12-13):271-2.

PMID:7808949
Abstract

Medical care of patients with hemophilia A and B involves regular ambulatory check-ups and contemporary replacement therapy. The Institute of Pediatrics in Lódź--as other medical centres in several countries--prophylactically treats some hemophilic patients, usually once per 7-10 days, with infusions of absent coagulation factor. Such treatment was carried out in 10 boys with severe hemophilia A and B with marked clinical symptoms. An analysis of health prior to and during prophylactic therapy was carried out. Such an analysis has shown that such a treatment is beneficial due to the shortening of hospitalization, change in the character of hemorrhage and possibility of rehabilitation free from the risk of complications.

摘要

甲型和乙型血友病患者的医疗护理包括定期门诊检查和现代替代疗法。罗兹的儿科研究所——与其他几个国家的医疗中心一样——对一些血友病患者进行预防性治疗,通常每7至10天一次,输注缺失的凝血因子。对10名患有严重甲型和乙型血友病且有明显临床症状的男孩进行了这种治疗。对预防性治疗前和治疗期间的健康状况进行了分析。该分析表明,这种治疗是有益的,因为它缩短了住院时间,改变了出血特征,并使康复成为可能且无并发症风险。

相似文献

1
[Prophylactic replacement therapy of hemophilia].[血友病的预防性替代治疗]
Pol Tyg Lek. 1994;49(12-13):271-2.
2
[SGPT increase in hemophilia patients during treatment with blood coagulation factor preparations].
Ned Tijdschr Geneeskd. 1979 Sep 1;123(35):1513-9.
3
[Advances in the field of hemophilia therapy].[血友病治疗领域的进展]
Ned Tijdschr Geneeskd. 1968 Sep 7;112(36):1593-5.
4
[Current status of hemophilia treatment].
Ned Tijdschr Geneeskd. 1979 Dec 8;123(49):2108-9.
5
Changing pattern of care of boys with haemophilia in western European centres.西欧血友病治疗中心男孩护理模式的变化
Haemophilia. 2005 Mar;11(2):92-9. doi: 10.1111/j.1365-2516.2005.01074.x.
6
10th Novo Nordisk Symposium on Haemostasis Management--introduction.第十届诺和诺德止血管理研讨会——引言
Haemophilia. 2010 May;16 Suppl 3:1-2. doi: 10.1111/j.1365-2516.2010.02251.x.
7
[Current treatment of hemophilia].
Tijdschr Ziekenverpl. 1985 Feb 26;38(5):144-7.
8
Treatment of haemophilia: building on strength in the third millennium.血友病的治疗:在第三个千年中巩固优势。
Haemophilia. 2011 Nov;17 Suppl 3:1-24. doi: 10.1111/j.1365-2516.2011.02657.x.
9
Treatment for hemophilia: recombinant versus plasma-derived coagulation factors - controversy and debate forever? An ethical medical challenge?
Expert Rev Hematol. 2013 Oct;6(5):489-92. doi: 10.1586/17474086.2013.834798. Epub 2013 Oct 2.
10
[Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].[修订版血友病共识:治疗与责任。荷兰血友病患者协会]
Ned Tijdschr Geneeskd. 1997 Dec 27;141(52):2566-71.